Work

Stratégie et mise en place d’une bactérie candidate médicament

Year: 2023
Type: dissertation
Abstract: In this work, I approach the subject of the gut microbiome from the point of view of the company YSOPIA Biosciences, which is developing a therapy based on the capabilities of an anaerobic bacterium. After a presentation of the gut microbiome and its role, you will find an overview of treatments and therapies based on the gut microbiome and an update on their regulatory status. Secondly, you will learn about the development process of the anaerobic bacterial strain C. minuta. This section includes a description of the strain, how it was developed in R&D and then produced at R&D scale under GMP conditions, and finally a description of the quality attributes approved by the FDA for Phase 1 clinical trials. Finally, you'll find the areas of development that I believe will enable a single bacterial strain PBL to reach the next stages of clinical development and marketing. This last part covers a number of essential points, such as optimisation of the production process, changes and consequent modifications to quality controls, development of techniques to ensure effective delivery to the site of administration and, finally, from a regulatory point of view, points of vigilance and what has been requested by the health authorities.
Source: HAL
Author: Bazin, Théo
Language: English
Subfield: Food Science
Open Access status: green
OpenAlex ID: W7043000395
Cites: 57
Cited by:
Related to: 10